NCT03557853View on ClinicalTrials.gov

Clinical and Radiological Manifestations of Coxitis in Patients With Ankylosing Spondylitis Treated With Golimumab

CompletedOBSERVATIONAL
Enrollment

39

Participants

Timeline

Start Date

June 30, 2016

Primary Completion Date

July 31, 2018

Study Completion Date

June 30, 2021

Conditions
Ankylosing SpondylitisCoxitis
Interventions
DRUG

Golimumab Injection

Simponi (golimumab) in fixed dose of 50 mg sc per month according to local label and local clinical practice.

Trial Locations (6)

Unknown

KhMAO Regional Clinical Hospital, Khanty-Mansiysk

Moscow Clinical Scientific Center, Moscow

Pirogov National Medical Surgical Center, Moscow

Rheumatology Research Institute, Moscow

Regional Clinical Hospital #2, Rostov-on-Don

City Clinical Hospital, Yakutsk

Sponsors
All Listed Sponsors
lead

MSD Pharmaceuticals LLC

INDUSTRY

NCT03557853 - Clinical and Radiological Manifestations of Coxitis in Patients With Ankylosing Spondylitis Treated With Golimumab | Biotech Hunter | Biotech Hunter